Volume 5, Issue 2 (2019)                   mazums-pbr 2019, 5(2): 29-32 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gholami F, Hosseini S H, Ahmadi A, Nabati M. A rare report of acute severe dyspnea, hemodynamic instability and cardiac arrest following crystal methamphetamine inhalation. mazums-pbr. 2019; 5 (2) :29-32
URL: http://pbr.mazums.ac.ir/article-1-226-en.html
Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences
Abstract:   (271 Views)
Abuse of amphetamine-like stimulants is a global problem. Myocardial infarction is a rarely reported complication of amphetamine abuse. Herein, we describe a 42-year-old man presented at the emergency department with complaints of severe dyspnea following ice inhalation without previous history of dyspnea. Within the first hour and a half after admission, the patient was initially treated by nasal oxygen and bronchodilator aminophylline. However, the patient did not respond to the initial treatment for severe dyspnea. Then, the patient developed loss of consciousness, ventricular fibrillation, cardiac arrest, and hemodynamic instability. Cardiopulmonary resuscitation (CPR) was immediately initiated. The patient was intubated, mechanically ventilated and administered synchronized electrical shock for five times (200-360 J) along with amiodarone (300 mg intravenously (IV), stat, then 1 mg/minute IV infusion for 6 hours and then 0.5 mg/minute for 18 hours) to treat the ventricular fibrillation. The arrhythmia was subsequently controlled, and normal sinus rhythm was resumed. Two hours later, the patient's condition was improved and he was extubated. After two days, when the patient got stable, the echocardiography after cardiac arrest performed and it was completely normal.
Type of Study: case report | Subject: Clinical Pharmacy

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb